In a nutshell This study examined whether loratadine (Claritin) or naproxen (Aleve) is better at treating bone pain associated with G-CSF treatment for patients undergoing chemotherapy for early stage breast cancer. This study concluded that there was no significant difference between the incidence of bone pain reported by patients...
Read MoreBreast cancer Posts on Medivizor
Endocrine therapy used with targeted therapy is associated with similar quality of life in comparison to endocrine therapy used alone.
In a nutshell This study aimed to find out if endocrine therapy (ET) is best used alone or with targeted therapy in the treatment of hormone positive, HER2 negative advanced breast cancer. The study found that patients who used ET and targeted therapy together experienced a better quality of life in some regards compared to ET used alone. Some...
Read MoreSearch for patients with breast cancer to test the treatment option of a probiotic
In a nutshell This trial is examining the effectiveness of a probiotic (Primal Defense Ultra (R) Probiotic Formula) for the immune systems of patients with breast cancer. The main outcome to be measured is the number of cytotoxic T lymphocytes (CD8+), a type of white blood cell. This study is being conducted in the Mayo Clinic in...
Read MoreLooking for patients undergoing breast core biopsy to test the effectiveness of nature sounds on anxiety reduction
In a nutshell This trial is examining the effectiveness of nature sounds to reduce pain and anxiety in patients undergoing breast core biopsy. The main outcome to be measured will be anxiety and pain scores. The study is being conducted in Chicago, Illinois, in the United States. The details A biopsy can be a stressful test for patients...
Read MoreLooking for patients with metastatic triple negative breast cancer to examine the effect of Nivolumab in combination with Cabozantinib
In a nutshell This trial is examining the effectiveness of nivolumab (Opdivo) in combination with cabozantinib (Cometriq) for metastatic triple-negative breast cancer (cancer that is not dependent on hormones or HER2 for growth). The outcome to be measured will be the response rate of the cancer to this treatment. This study is...
Read MoreLooking for patients with HER2-positive inoperable breast cancer to examine the efficacy and safety of antibody-drug conjugate SYD985
In a nutshell This trial is examining the effectiveness of the antibody-drug conjugate SYD985 for HER2-positive inoperable advanced breast cancer. The main outcome to be measured will be time from treatment until disease progression or the time taken for tumor growth or spread. This study is being conducted in Baltimore, Maryland, inthe United...
Read MoreLooking for patients with breast cancer who will be undergoing mastectomy to examine the incidence of chronic pain when Pulsed Electromagnetic Fields (PEMF) and Pectoral (PEC) Interfascial Blocks are used.
In a nutshell This trial is examining the effectiveness of pulsed electromagnetic field (PEMF) or an anesthetic bupivacaine in lowering the incidence of chronic pain after surgery. The main outcome to be measured will be the incidence of chronic pain after each treatment. This study is being conducted in New York City. The...
Read MoreTo Treat or Not To Treat Cancer: Medical Decision-making
Cherry Hughes** is an active, energetic 75 year old, still working in the marketing and public relations profession in Great Britain. Her life is filled with friends and fun. “I love cooking and eating out. I am deeply interested in politics. I love music …I go to jazz clubs. I love going to France …I have a little apartment...
Read MoreAlcohol consumption’s effect on breast cancer mortality
In a nutshell This study aimed to examine the effect alcohol consumption has on patients with breast cancer. This study concluded that low, moderate and high levels of alcohol intake were not associated with an increased chance of mortality as compared to non-drinkers. Some background Alcohol intake is a known risk factor for breast cancer...
Read MoreWhat is Neutropenia?
There are 1.6 million people diagnosed with cancer in the US each year. Of these, 650,000 receive chemotherapy. Did you know that 60,000 people a year are hospitalized for neutropenia, a common side effect of chemotherapy? One in fourteen die because of it. Of the 650,000 receiving chemotherapy, 104,000 are not aware of neutropenia and 52,000 don’t...
Read MorePost-traumatic stress disorder can develop in patients with cancer
In a nutshell This study aimed to evaluate post-traumatic stress disorder (PTSD) in patients who have had treatment for cancer. This study found that a number of patients undergoing cancer treatment developed PTSD after treatment and recommended that supports are put in place. Some background Post-traumatic stress disorder (PTSD) is a...
Read MorePost-traumatic stress disorder can develop in patients with cancer
In a nutshell This study aimed to evaluate post-traumatic stress disorder (PTSD) in patients who have had treatment for cancer. This study found that a number of patients undergoing cancer treatment developed PTSD after treatment and recommended that supports are put in place. Some background Post-traumatic stress disorder (PTSD) is a...
Read More